+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid induced hypercholeresis in a patient with primary biliary cirrhosis



Ursodeoxycholic acid induced hypercholeresis in a patient with primary biliary cirrhosis



Hepatology 18(4 Part 2): 297A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144860

Download citation: RISBibTeXText


Related references

Hypercholeresis induced by ursodeoxycholic acid in primary biliary cirrhosis. Journal of Hepatology 18(Suppl. 1): S120, 1993

Changes induced by ursodeoxycholic acid udca administration on biliary and serum bile acid composition in patients with primary biliary cirrhosis pbc. Hepatology 12(4 Part 2): 995, 1990

Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat. Hepatology 52(2): 667-677, 2010

Deterioration in primary biliary cirrhosis in patient on ursodeoxycholic acid. Lancet 2(8603): 166-167, 1988

Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis. Netherlands Journal of Medicine 37(1-2): 21-23, 1990

Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis. Digestive and Liver Disease 42(12): 911-912, 2011

Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. Journal of Hepatology 25(1): 49-57, 1996

Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone. Journal of Hepatology 18(1): 9-14, 1993

The effects of colchicine and methotrexate are additive to ursodeoxycholic acid for patients with primary biliary cirrhosis who respond incompletely to ursodeoxycholic acid. Hepatology 26(4 Part 2): 438A, 1997

Therapeutic Equivalence of Ursodeoxycholic Acid Tablets and Ursodeoxycholic Acid Capsules for the Treatment of Primary Biliary Cirrhosis. Clinical Pharmacology in Drug Development 2(3): 231-236, 2013

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 24(5): 1098-1103, 1996

The Italian multi-centre randomized controlled trial of ursodeoxycholic acid vs ursodeoxycholic acid plus colchicine in symptomatic primary biliary cirrhosis. Hepatology 20(4 Part 2): 267A, 1994

Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis. Hepatology Research 39(5): 448-454, 2009

Ursodeoxycholic acid in primary biliary cirrhosis. 1: Therapeutic approaches up to now and the rationale for treatment with ursodeoxycholic acid. Fortschritte der Medizin 106(34): 691-694, 1988